A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN)
Article in Diabetes Obesity and Metabolism (May 2024)
The most recent citing publications are shown below. View all 332 publications that cite this research output on Dimensions.
Article in Diabetes Obesity and Metabolism (May 2024)
Article in Diabetes Therapy (April 2024)
Article in Diabetes Obesity and Metabolism (April 2024)